TOP STORIES

• REGULATORY MOF Panel’s Budget Proposal Pushes Macroeconomic Indexing, No Adjustment Rate
  December 6, 2021

• BUSINESS MSD Files Oral COVID-19 Drug in Japan
  December 3, 2021

• REGULATORY Average NHI-Market Price Gap of Listed Drugs at 7.6%: MHLW
  December 3, 2021

• REGULATORY Chuikyo Members Call for Restrictions in Re-Pricing Exclusions from Spillover Rule
  December 2, 2021

• BUSINESS Blaze at Hitachi Logistic Center Could Add to Drug Supply Woes
  December 1, 2021

• REGULATORY Japan Confirms 1st Case of Omicron Variant: MHLW
  December 1, 2021

• REGULATORY Alzheimer’s Drugs in Mind, MHLW to Float New Rule for Potential Super Big Sellers
  November 30, 2021

• BUSINESS Takeda’s GI Biz Poised for Growth with 3 Products Now in Its Lineup
  November 29, 2021

• REGULATORY Japan Approves Jardiance for Heart Failure, Label Expansions for Opdivo and Keytruda
  November 26, 2021

• REGULATORY Pharma Pushes 2% Adjustment Rate Plus Certain Range in 2022 Drug Price Revision
  November 26, 2021

• REGULATORY Sanofi’s Praluent to Be Taken Off Japan NHI Price List Next Spring
  November 26, 2021

• REGULATORY LDP Health Panel Chief Vows to Push Development of Japan-Made Vaccines and Drugs
  November 25, 2021

• BUSINESS Top 3 Japan Generic Makers Face Uphill Struggle Overseas in April-September: Jiho Tally
  November 25, 2021

• BUSINESS Japan Biz of Top 3 Generic Makers in H1 Impacted by GMP Issues, Substitution Demand: Jiho Tally
  November 25, 2021

• BUSINESS Alnylam to File Its Third Drug in Japan 3 Years after Market Entry, Eyes CNS Therapies
  November 24, 2021

• ORGANIZATION 20% of Listed Drugs in Japan, Mostly Generics, Hit by Supply Issues: FPMAJ Survey
  November 22, 2021

• REGULATORY Japan OKs 56 Trillion Yen Stimulus Package, Spells Out Support for Japan-Made Drugs and Vaccines
  November 22, 2021

• BUSINESS Top 4 Wholesalers’ Average Operating Margin at 0.46% on Tough Price Negotiations: H1 FY2021 Earnings
  November 22, 2021

• REGULATORY Japan Panel Discusses Safety, Immunity Rules for Envisaged Emergency Approval Scheme
  November 19, 2021

• REGULATORY Ex-Minister Tamura Says Efficacy/Safety Confirmation Important in Emergency Approval, Wary on Macroeconomic Indexing
  November 18, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 81
• 82
• 83
• 84
• 85
• 86
• 87
• 88
• 89
• …
• Next ›
• 最終 »